Last reviewed · How we verify

NCT05720962

The Effect of Continuous Accompanying Support in the Active Phase on Labor Pain, Duration and Satisfaction

Completed NA Last updated 6 March 2024
What this trial tests

NA trial testing uninterrupted accompanying support in Continuous Birth Support in 110 participants. Completed in 1 March 2024.

Timeline
1 January 2023
Primary endpoint
1 January 2024
1 March 2024

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment110
Start date1 January 2023
Primary completion1 January 2024
Estimated completion1 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 18 to 35, female only, with Continuous Birth Support. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to determine the effect of continuous accompanying support during the active phase on labor pain, duration and satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05720962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing